Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Deloitte
AstraZeneca
Express Scripts
Accenture
Dow
Moodys
QuintilesIMS

Generated: November 15, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Fruquintinib

« Back to Dashboard

US Patents for Fruquintinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fruquintinib ➤ Try a Free Trial Substituted quinazoline compounds and their use in treating angiogenesis-related diseases Hutchison MediPharma Enterprises Limited (BS) ➤ Try a Free Trial
Fruquintinib ➤ Try a Free Trial Use of substituted quinazoline compounds in treating angiogenesis-related diseases Hutchison Medipharma Enterprises Limited (Nassau, BS) ➤ Try a Free Trial
Fruquintinib ➤ Try a Free Trial Use of substituted quinazoline compounds in treating age-related macular degeneration Hutchison Medipharma Enterprises Limited (Nassau, BS) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Fruquintinib

Drugname Country Document Number Estimated Expiration Related US Patent
Fruquintinib Australia 2009244130 2028-05-09 ➤ Try a Free Trial
Fruquintinib Brazil PI0908675 2028-05-09 ➤ Try a Free Trial
Fruquintinib Canada 2723148 2028-05-09 ➤ Try a Free Trial
Fruquintinib Cyprus 1117222 2028-05-09 ➤ Try a Free Trial
Fruquintinib Denmark 2297115 2028-05-09 ➤ Try a Free Trial
Fruquintinib European Patent Office 2297115 2028-05-09 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Healthtrust
Queensland Health
Colorcon
Chubb
Cerilliant
UBS
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.